Membrane-bound human SCF/KL promotes in vivo human hematopoietic engraftment and myeloid differentiation

Blood

Volumn 119, Issue 12, 2012, Pages 2768-2777

  Takagi, Shinsuke ^a,b,c   Saito, Yoriko ^a   Hijikata, Atsushi ^a   Tanaka, Satoshi ^a,d,e   Watanabe, Takashi ^a   Hasegawa, Takanori ^a   Mochizuki, Shinobu ^a   Kunisawa, Jun ^d   Kiyono, Hiroshi ^d   Koseki, Haruhiko ^a   Ohara, Osamu ^a,f   Saito, Takashi ^a,c   Taniguchi, Shuichi ^b   Shultz, Leonard D ^g   Ishikawa, Fumihiko ^a  

^a RIKEN Center for Integrative Medical Sciences   (Japan)

^b TORANOMON HOSPITAL   (Japan)

^c CHIBA UNIVERSITY   (Japan)

^d UNIVERSITY OF TOKYO   (Japan)

^e Nippon Becton Dickinson Company   (Japan)

^f KAZUSA DNA RESEARCH INSTITUTE   (Japan)

^g JACKSON LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD33 ANTIGEN; CD45 ANTIGEN; COMPLEMENTARY DNA; RNA; STEM CELL FACTOR;

ANIMAL EXPERIMENT; ARTICLE; BONE MARROW; BONE MARROW CELL; CELL DIFFERENTIATION; FLOW CYTOMETRY; GASTROINTESTINAL TRACT; GRANULOCYTE; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MAST CELL; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SCID MOUSE; SPLEEN; TRANSGENIC MOUSE; XENOTRANSPLANTATION;

EID: 84863337646     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2011-05-353201     Document Type: Article

References (41)

1. Manz MG. Human-hemato-lymphoid-system mice: opportunities and challenges. Immunity. 2007;26(5):537-541. (Pubitemid 46756351)
2. Shultz LD, Ishikawa F, Greiner DL. Humanized mice in translational biomedical research. Nat Rev Immunol. 2007;7(2):118-130. (Pubitemid 46174859)
3. McCune JM, Namikawa R, Kaneshima H, Shultz LD, Lieberman M,Weissman IL. The SCID-hu mouse: murine model for the analysis of human hematolymphoid differentiation and function. Science. 1988;241(4873):1632-1639.
4. Mosier DE, Gulizia RJ, Baird SM, Wilson DB. Transfer of a functional human immune system to mice with severe combined immunodeficiency. Nature. 1988;335(6187):256-259.
5. Ishikawa F, Yasukawa M, Lyons B, et al. Development of functional human blood and immune systems in NOD/SCID/IL2 receptor gamma chain-(null) mice. Blood. 2005;106(5):1565-1573. (Pubitemid 41208567)
6. Ito M, Hiramatsu H, Kobayashi K, et al. NOD/ SCID/gamma(c)(null) mouse: an excellent recipient mouse model for engraftment of human cells. Blood. 2002;100(9):3175-3182. (Pubitemid 35217065)
7. Shultz LD, Banuelos S, Lyons B, et al. NOD/LtSz-Rag1nullPfpnull mice: a new model system with increased levels of human peripheral leukocyte and hematopoietic stem-cell engraftment. Transplantation. 2003;76(7):1036-1042. (Pubitemid 37280830)
8. Shultz LD, Lyons BL, Burzenski LM, et al. Human lymphoid and myeloid cell development in NOD/ LtSz-scid IL2R gamma null mice engrafted with mobilized human hemopoietic stem cells. J Immunol. 2005;174(10):6477-6489. (Pubitemid 40663843)
9. Traggiai E, Chicha L, Mazzucchelli L, et al. Development of a human adaptive immune system in cord blood cell-transplanted mice. Science. 2004; 304(5667):104-107. (Pubitemid 38451466)
10. Strowig T, Gurer C, Ploss A, et al. Priming of protective T cell responses against virus-induced tumors in mice with human immune system components. J Exp Med. 2009;206(6):1423-1434.
11. Jaiswal S, Pearson T, Friberg H, et al. Dengue virus infection and virus-specific HLA-A2 restricted immune responses in humanized NODscid IL2rgammanull mice. PLoS One. 2009;4(10): e7251.
12. Shultz LD, Saito Y, Najima Y, et al. Generation of functional human T-cell subsets with HLA-restricted immune responses in HLA class I expressing NOD/SCID/IL2r gamma(null) humanized mice. Proc Natl Acad Sci U S A. 2010; 107(29):13022-13027.
13. Majumdar MK, Everett ET, Xiao X, et al. Xenogeneic expression of human stem cell factor in transgenic mice mimics codominant c-kit mutations. Blood. 1996;87(8):3203-3211. (Pubitemid 26115349)
14. Hong F, Breitling R, McEntee CW, et al. Rank-Prod: a bioconductor package for detecting differentially expressed genes in meta-analysis. Bioinformatics. 2006;22(22):2825-2827. (Pubitemid 44742407)
15. Draghici S, Khatri P, Martins RP, et al. Global functional profiling of gene expression. Genomics. 2003;81(2):98-104. (Pubitemid 36298600)
16. Benjamini Y, Hochberg Y, et al. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc B Met. 1995;57(1):289-300.
17. Kawashima I, Zanjani ED, Almaida-Porada G, Flake AW, Zeng H, Ogawa M. CD34+ human marrow cells that express low levels of Kit protein are enriched for long-term marrow-engrafting cells. Blood. 1996;87(10):4136-4142. (Pubitemid 26152257)
18. Sakabe H, Kimura T, Zeng Z, et al. Haematopoietic action of flt3 ligand on cord blood-derived CD34-positive cells expressing different levels of flt3 or c-kit tyrosine kinase receptor: comparison with stem cell factor. Eur J Haematol. 1998;60(5): 297-306. (Pubitemid 28270754)
19. Yoshikubo T, Inoue T, Noguchi M, Okabe H. Differentiation and maintenance of mast cells from CD34+ human cord blood cells. Exp Hematol. 2006;34(3):320-329.
20. Hiramatsu H, Nishikomori R, Heike T, et al. Complete reconstitution of human lymphocytes from cord blood CD34+ cells using the NOD/SCID/ gammacnull mice model. Blood. 2003;102(3): 873-880. (Pubitemid 36917778)
21. Arinobu Y, Iwasaki H, Gurish MF, et al. Developmental checkpoints of the basophil/mast cell lineages in adult murine hematopoiesis. Proc Natl Acad Sci U S A. 2005;102(50):18105-18110. (Pubitemid 41798509)
22. Kiel MJ, Morrison SJ. Uncertainty in the niches that maintain haematopoietic stem cells. Nat Rev Immunol. 2008;8(4):290-301. (Pubitemid 351432804)
23. Jenkinson EJ, Jenkinson WE, Rossi SW, Anderson G. The thymus and T-cell commitment: the right niche for Notch? Nat Rev Immunol. 2006;6(7):551-555. (Pubitemid 43980527)
24. Toksoz D, Zsebo KM, Smith KA, et al. Support of human hematopoiesis in long-term bone marrow cultures by murine stromal cells selectively expressing the membrane-bound and secreted forms of the human homolog of the steel gene product, stem cell factor. Proc Natl Acad Sci U S A. 1992;89(16):7350-7354.
25. Besmer P, Manova K, Duttlinger R, et al. The kitligand (steel factor) and its receptor c-kit/W: pleiotropic roles in gametogenesis and melanogenesis. Dev Suppl. 1993;125-137. (Pubitemid 24139754)
26. Geissler EN, McFarland EC, Russell ES. Analysis of pleiotropism at the dominant white-spotting (W) locus of the house mouse: a description of ten new W alleles. Genetics. 1981;97(2):337-361.
27. Russell ES. Hereditary anemias of the mouse: a review for geneticists. Adv Genet. 1979;20:357-459.
28. Broudy VC. Stem cell factor and hematopoiesis. Blood. 1997;90(4):1345-1364. (Pubitemid 27355406)
29. Leary AG, Zeng HQ, Clark SC, Ogawa M. Growth factor requirements for survival in G0 and entry into the cell cycle of primitive human hemopoietic progenitors. Proc Natl Acad Sci U S A. 1992; 89(9):4013-4017.
30. Bernstein ID, Andrews RG, Zsebo KM. Recombinant human stem cell factor enhances the formation of colonies by CD34+ and CD34+lin- cells, and the generation of colony-forming cell progeny from CD34+lin- cells cultured with interleukin-3, granulocyte colony-stimulating factor, or granulocyte-macrophage colony-stimulating factor. Blood. 1991;77(11):2316-2321.
31. Haylock DN, To LB, Dowse TL, Juttner CA, Simmons PJ. Ex vivo expansion and maturation of peripheral blood CD34+ cells into the myeloid lineage. Blood. 1992;80(6):1405-1412.
32. Petzer AL, Hogge DE, Landsdorp PM, Reid DS, Eaves CJ. Self-renewal of primitive human hematopoietic cells (long-term-culture-initiating cells) in vitro and their expansion in defined medium. Proc Natl Acad Sci U S A. 1996;93(4):1470-1474.
33. Lev S, Yarden Y, Givol D. Dimerization and activation of the kit receptor by monovalent and bivalent binding of the stem cell factor. J Biol Chem. 1992;267(22):15970-15977.
34. Martin FH, Suggs SV, Langley KE, et al. Primary structure and functional expression of rat and human stem cell factor DNAs. Cell. 1990;63(1):203-211.
35. Terstappen LW, Safford M, Loken MR. Flow cytometric analysis of human bone marrow: III. Neutrophil maturation. Leukemia. 1990;4(9):657-663. (Pubitemid 20328151)
36. Pardanani A. Systemic mastocytosis in adults: 2011 update on diagnosis, risk stratification, and management. Am J Hematol. 2011;86(4):362-371.
37. Sotlar K, Cerny-Reiterer S, Petat-Dutter K, et al. Aberrant expression of CD30 in neoplastic mast cells in high-grade mastocytosis. Mod Pathol. 2011;24(4):585-595.
38. Rongvaux A, Willinger T, Takizawa H, et al. Human thrombopoietin knockin mice efficiently support human hematopoiesis in vivo. Proc Natl Acad Sci U S A. 2011;108(6):2378-2383.
39. Pearson T, Shultz LD, Miller D, et al. Non-obese diabetic-recombination activating gene-1 (NODRag1 null) interleukin (IL)-2 receptor common gamma chain (IL2r gamma null) null mice: a radioresistant model for human lymphohaematopoietic engraftment. Clin Exp Immunol. 2008;154(2): 270-284.
40. Brehm MA, Cuthbert A, Yang C, et al. Parameters for establishing humanized mouse models to study human immunity: analysis of human hematopoietic stem cell engraftment in three immunodeficient strains of mice bearing the IL2rgamma(null) mutation. Clin Immunol. 2010;135(1):84-98.
41. Strowig T, Rongvaux A, Rathinam C, et al. Transgenic expression of human signal regulatory protein alpha in Rag2-/- gammac-/- mice improves engraftment of human hematopoietic cells in humanized mice. Proc Natl Acad Sci U S A. 2011;108(32):13218-13223.